The microRNA (miR) profile in B-cell chronic lymphocytic leukemia (CLL) reveals a differential expression of miR-21, miR-155 and miR-150 between leukemic and normal B lymphocytes, and of miR-150, miR-29bc and miR-223 between IgVH mutated and unmutated patients.

被引：0
|
作者：
Chiaretti, Sabina [1 ]
Fulci, Valerio [1 ]
Goldoni, Marina [1 ]
Azzalin, Gianluca [1 ]
Tavolaro, Simona [1 ]
Messina, Monica [1 ]
Maggio, Roberta [1 ]
Peragine, Nadia [1 ]
Santangelo, Simona [1 ]
Mauro, Francesca R. [1 ]
Guarini, Anna [1 ]
Macino, Giuseppe [1 ]
Foa, Robert [1 ]
机构：
[1] Univ Roma La Sapienza, Rome, Italy
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.298.298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
298
引用
收藏
页码：92A / 92A
页数：1
相关论文
共 9 条
  • [1] Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients
    Raeisi, Farzaneh
    Mahmoudi, Esmaeil
    Dehghani-Samani, Mina
    Hosseini, Seyedeh Sahar Ebrahimi
    Ghahfarrokhi, Ameneh Mehri
    Arshi, Asghar
    Forghanparast, Kayvan
    Ghazanfari, Samaneh
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 16 : 230 - 237
  • [2] Differential Expression of miR-155 and miR-21 in Tumor and Stroma Cells in Diffuse Large B-Cell Lymphoma
    Munch-Petersen, Helga D.
    Ralfkiaer, Ulrik
    Sjo, Lene D.
    Hother, Christoffer
    Asmar, Fazila
    Nielsen, Boye S.
    Brown, Peter
    Ralfkiaer, Elisabeth
    Gronbaek, Kirsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (03) : 188 - 195
  • [3] MICRORNA MIR-150 CONTRIBUTES TO THE DISEASE AGGRESSIVENESS AND REGULATION OF B-CELL RECEPTOR SIGNALLING (BCR) IN CLL
    Mraz, M.
    Rassenti, L.
    Chen, L.
    Ghia, E.
    Li, H.
    Messer, K.
    Jepsen, K.
    Smith, E.
    Frazer, K.
    Kipps, T.
    HAEMATOLOGICA, 2013, 98 : 291 - 291
  • [4] miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1
    Mraz, Marek
    Chen, Liguang
    Rassenti, Laura Z.
    Ghia, Emanuela M.
    Li, Hongying
    Jepsen, Kristen
    Smith, Erin N.
    Messer, Karen
    Frazer, Kelly A.
    Kipps, Thomas J.
    BLOOD, 2014, 124 (01) : 84 - 95
  • [5] miRNA analysis in B-cell chronic lymphocytic leukaemia:: proliferation centres characterized by low miR-150 and high BIC/milk-155 expression
    Wang, M.
    Tan, L. P.
    Dijkstra, M. K.
    van Lom, K.
    Robertus, J-L
    Harms, G.
    Blokzijl, T.
    Kooistra, K.
    van t'Veer, M. B.
    Rosati, S.
    Visser, L.
    Jongen-Lavrencic, M.
    Kluin, P. M.
    van den Berg, A.
    JOURNAL OF PATHOLOGY, 2008, 215 (01): : 13 - 20
  • [6] Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia
    Ferrajoli, Alessandra
    Shanafelt, Tait D.
    Ivan, Cristina
    Shimizu, Masayoshi
    Rabe, Kari G.
    Nouraee, Nazila
    Ikuo, Mariko
    Ghosh, Asish K.
    Lerner, Susan
    Rassenti, Laura Z.
    Xiao, Lianchun
    Hu, Jianhua
    Reuben, James M.
    Calin, Steliana
    You, M. James
    Manning, John T.
    Wierda, William G.
    Estrov, Zeev
    O'Brien, Susan
    Kipps, Thomas J.
    Keating, Michael J.
    Kay, Neil E.
    Calin, George A.
    BLOOD, 2013, 122 (11) : 1891 - 1899
  • [7] Association Between the Proficiency of B-Cell Receptor Signaling and the Relative Expression Levels of ZAP-70, SHIP-1, and Mir-155 in Chronic Lymphocytic Leukemia
    Chen, Liguang
    Cui, Bing
    Zhang, Suping
    Chen, George
    Croce, Carlo M.
    Kipps, Thomas J.
    BLOOD, 2008, 112 (11) : 1082 - 1082
  • [8] The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
    Boysen, J.
    Sinha, S.
    Price-Troska, T.
    Warner, S. L.
    Bearss, D. J.
    Viswanatha, D.
    Shanafelt, T. D.
    Kay, N. E.
    Ghosh, A. K.
    LEUKEMIA, 2014, 28 (02) : 451 - 455
  • [9] The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
    J Boysen
    S Sinha
    T Price-Troska
    S L Warner
    D J Bearss
    D Viswanatha
    T D Shanafelt
    N E Kay
    A K Ghosh
    Leukemia, 2014, 28 : 451 - 455
1